Hepatic absorbed radiation dosimetry during I-131 Metaiodobenzylguanadine (MIBG) therapy for refractory neuroblastoma

被引：0
|
作者：
Kenneth F. Koral
John P. Huberty
Bill Frame
Katherine K. Matthay
John M. Maris
Denise Regan
Daniel Normolle
Gregory A. Yanik
机构：
[1] University of Michigan,Department of Radiology, Nuclear Medicine Division
[2] University of California San Francisco,Department of Nuclear Medicine
[3] University of Michigan Comprehensive Cancer Center,Biostatistics Unit
[4] University of California San Francisco,Department of Pediatrics
[5] Children’s Hospital of Philadelphia,Department of Pediatrics
[6] University of Michigan,Department of Radiation Oncology
[7] University of Michigan,Department of Pediatrics
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2008年 / 35卷
关键词：
Dosimetry; Liver disease; Radionuclide therapy; Iodine-131; MIBG neuroblastoma oncology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2105 / 2112
页数：7
相关论文
共 50 条
  • [1] Hepatic absorbed radiation dosimetry during I-131 Metaiodobenzylguanadine (MIBG) therapy for refractory neuroblastoma
    Koral, Kenneth F.
    Huberty, John P.
    Frame, Bill
    Matthay, Katherine K.
    Maris, John M.
    Regan, Denise
    Normolle, Daniel
    Yanik, Gregory A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (11) : 2105 - 2112
  • [2] Absorbed dose ratios for repeated therapy of neuroblastoma with I-131 mIBG
    Flux, GD
    Guy, MJ
    Papavasileiou, P
    South, C
    Chittenden, SJ
    Flower, MA
    Meller, ST
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (01) : 81 - 87
  • [3] Radiation dosimetry for I-131-mIBG therapy of neuroblastoma
    Flower, MA
    Fielding, SL
    PHYSICS IN MEDICINE AND BIOLOGY, 1996, 41 (10): : 1933 - 1940
  • [4] Acute toxicities of I-131 MIBG therapy in patients with refractory neuroblastoma
    Kayano, D.
    Wakabayashi, H.
    Inaki, A.
    Toratani, A.
    Fukuoka, M.
    Kinuya, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S398 - S398
  • [5] CALCULATING RADIATION ABSORBED DOSE FOR PHEOCHROMOCYTOMA TUMORS IN I-131 MIBG THERAPY
    KORAL, KF
    WANG, XH
    SISSON, JC
    BOTTI, J
    MEYER, L
    MALLETTE, S
    GLAZER, GM
    ADLER, RS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (01): : 211 - 218
  • [6] DOSIMETRIC CONSIDERATIONS IN I-131 MIBG THERAPY FOR NEUROBLASTOMA IN CHILDREN
    BOLSTER, AA
    HILDITCH, TE
    BRITISH JOURNAL OF RADIOLOGY, 1995, 68 (815): : 1263 - 1263
  • [7] A MULTIDISCIPLINARY APPROACH TO I-131 MIBG THERAPY FOR THE TREATMENT OF NEUROBLASTOMA
    Lambrinos, Elaine
    Lurvey, Megan
    Spidle, Jennifer
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S546 - S547
  • [8] Radiation exposure to caregivers of pediatric neuroblastoma patients undergoing I-131 MIBG therapy
    Markelewicz, Robert
    Lorenzen, William
    Fahey, Frederic
    Treves, S. Ted
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [9] DOSIMETRIC CONSIDERATIONS IN I-131 MIBG THERAPY FOR NEUROBLASTOMA IN CHILDREN
    BOLSTER, AA
    HILDITCH, TE
    WHELDON, TE
    GAZE, MN
    BARRETT, A
    BRITISH JOURNAL OF RADIOLOGY, 1995, 68 (809): : 481 - 490
  • [10] Survival of neuroblastoma after I-131 MIBG therapy at diagnosis.
    Hoefnagel, CA
    deKraker, J
    Olmos, RAV
    Caron, H
    Voute, PA
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 1067 - 1067
12345